Connection

MIGUEL A RODRIGUEZ-BIGAS to Adult

This is a "connection" page, showing publications MIGUEL A RODRIGUEZ-BIGAS has written about Adult.
Connection Strength

0.528
  1. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience. J Surg Oncol. 2014 Jun; 109(7):652-8.
    View in: PubMed
    Score: 0.019
  2. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis. Ann Surg Oncol. 2013 Feb; 20(2):482-90.
    View in: PubMed
    Score: 0.017
  3. Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):824-30.
    View in: PubMed
    Score: 0.014
  4. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma. Ann Surg Oncol. 2007 Jun; 14(6):1870-7.
    View in: PubMed
    Score: 0.012
  5. Early postoperative oral feeding after colectomy: an analysis of factors that may predict failure. Ann Surg Oncol. 2001 Dec; 8(10):796-800.
    View in: PubMed
    Score: 0.008
  6. Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer. Clin Colorectal Cancer. 2022 03; 21(1):e28-e37.
    View in: PubMed
    Score: 0.008
  7. Fertility discussions in young adult stage III colorectal cancer population: a single-center institution experience. Support Care Cancer. 2021 Dec; 29(12):7351-7354.
    View in: PubMed
    Score: 0.008
  8. Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations. Ann Surg Oncol. 2001 May; 8(4):319-27.
    View in: PubMed
    Score: 0.008
  9. Rectal cancer in hereditary nonpolyposis colorectal cancer. Am J Surg. 2001 Mar; 181(3):207-10.
    View in: PubMed
    Score: 0.008
  10. A Phase II Study of Capecitabine/Oxaliplatin With Concurrent Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Anal Canal. Clin Colorectal Cancer. 2019 12; 18(4):301-306.
    View in: PubMed
    Score: 0.007
  11. Outcomes of disease-specific next-generation sequencing gene panel testing in adolescents and young adults with colorectal cancer. Cancer Genet. 2019 06; 235-236:77-83.
    View in: PubMed
    Score: 0.007
  12. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine. Dis Colon Rectum. 2019 04; 62(4):429-437.
    View in: PubMed
    Score: 0.007
  13. Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features. Int J Cancer. 2019 05 01; 144(9):2161-2168.
    View in: PubMed
    Score: 0.007
  14. Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International Collaborative Group on HNPCC. Cancer. 1998 Jul 15; 83(2):240-4.
    View in: PubMed
    Score: 0.006
  15. Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive Chemoradiation. Am J Clin Oncol. 2018 07; 41(7):632-637.
    View in: PubMed
    Score: 0.006
  16. Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Biliary Tract Cancers Associated with Lynch Syndrome. J Gastrointest Cancer. 2018 Mar; 49(1):93-96.
    View in: PubMed
    Score: 0.006
  17. Assessment of Ileostomy Output Using Telemedicine: A Feasibility Trial. Dis Colon Rectum. 2018 Jan; 61(1):77-83.
    View in: PubMed
    Score: 0.006
  18. Clinical features and survival of gastric cancer patients with DNA mismatch repair deficiency. J Surg Oncol. 2018 Mar; 117(4):707-709.
    View in: PubMed
    Score: 0.006
  19. In Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular Validation. Cancer Prev Res (Phila). 2017 Oct; 10(10):580-587.
    View in: PubMed
    Score: 0.006
  20. Identification of MSH2 inversion of exons 1-7 in clinical evaluation of families with suspected Lynch syndrome. Fam Cancer. 2017 07; 16(3):357-361.
    View in: PubMed
    Score: 0.006
  21. Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer. J Clin Oncol. 2017 Aug 10; 35(23):2631-2638.
    View in: PubMed
    Score: 0.006
  22. Can Microsatellite Status of Colorectal Cancer Be Reliably Assessed after Neoadjuvant Therapy? Clin Cancer Res. 2017 Sep 01; 23(17):5246-5254.
    View in: PubMed
    Score: 0.006
  23. Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum. Am J Clin Oncol. 2017 Apr; 40(2):163-166.
    View in: PubMed
    Score: 0.006
  24. A comparison between Lynch syndrome and sporadic colorectal cancer survivors' satisfaction with their healthcare providers. Cancer Med. 2017 03; 6(3):698-707.
    View in: PubMed
    Score: 0.006
  25. Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity. Radiother Oncol. 2017 01; 122(1):146-151.
    View in: PubMed
    Score: 0.006
  26. Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer. Oncotarget. 2016 Nov 15; 7(46):76250-76260.
    View in: PubMed
    Score: 0.006
  27. Adenosquamous carcinoma of the colon and rectum. Dis Colon Rectum. 1996 Nov; 39(11):1265-8.
    View in: PubMed
    Score: 0.006
  28. Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer. Cancer. 2017 04 01; 123(7):1124-1133.
    View in: PubMed
    Score: 0.006
  29. Colorectal cancer in patients aged 30 years or younger. Surg Oncol. 1996 Aug; 5(4):189-94.
    View in: PubMed
    Score: 0.006
  30. DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics. J Clin Oncol. 2016 09 01; 34(25):3039-46.
    View in: PubMed
    Score: 0.006
  31. Prophylactic colectomy for gene carriers in hereditary nonpolyposis colorectal cancer. Has the time come? Cancer. 1996 Jul 15; 78(2):199-201.
    View in: PubMed
    Score: 0.006
  32. Establishment of a hereditary nonpolyposis colorectal cancer registry. Dis Colon Rectum. 1996 Jun; 39(6):649-53.
    View in: PubMed
    Score: 0.006
  33. Impact of multimodal therapy in locally recurrent rectal cancer. Br J Surg. 2016 May; 103(6):753-762.
    View in: PubMed
    Score: 0.005
  34. Clinical significance of colorectal cancer: metastases in lymph nodes < 5 mm in size. Ann Surg Oncol. 1996 Mar; 3(2):124-30.
    View in: PubMed
    Score: 0.005
  35. Intraoperative small bowel enteroscopy in familial adenomatous and familial juvenile polyposis. Gastrointest Endosc. 1995 Dec; 42(6):560-4.
    View in: PubMed
    Score: 0.005
  36. High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer. J Clin Oncol. 2015 Nov 01; 33(31):3544-9.
    View in: PubMed
    Score: 0.005
  37. A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal Cancer. J Natl Compr Canc Netw. 2015 Jul; 13(7):865-72.
    View in: PubMed
    Score: 0.005
  38. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. JAMA Surg. 2015 May; 150(5):402-9.
    View in: PubMed
    Score: 0.005
  39. An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis. Gut. 2016 Feb; 65(2):286-95.
    View in: PubMed
    Score: 0.005
  40. Time trend analysis of primary tumor resection for stage IV colorectal cancer: less surgery, improved survival. JAMA Surg. 2015 Mar 01; 150(3):245-51.
    View in: PubMed
    Score: 0.005
  41. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 2015 Jan; 150(1):17-22.
    View in: PubMed
    Score: 0.005
  42. The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal. Oncotarget. 2014 Nov 30; 5(22):11133-42.
    View in: PubMed
    Score: 0.005
  43. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer. Cancer Genet. 2014 Oct-Dec; 207(10-12):495-502.
    View in: PubMed
    Score: 0.005
  44. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol. 2014 Sep 20; 32(27):2967-74.
    View in: PubMed
    Score: 0.005
  45. Functional deficits and symptoms of long-term survivors of colorectal cancer treated by multimodality therapy differ by age at diagnosis. J Gastrointest Surg. 2015 Jan; 19(1):180-8; discussio 188.
    View in: PubMed
    Score: 0.005
  46. Desmoid tumors in patients with familial adenomatous polyposis. Cancer. 1994 Aug 15; 74(4):1270-4.
    View in: PubMed
    Score: 0.005
  47. Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program. Surg Oncol. 1994 Feb; 3(1):27-36.
    View in: PubMed
    Score: 0.005
  48. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial. Int J Radiat Oncol Biol Phys. 2014 Feb 01; 88(2):301-5.
    View in: PubMed
    Score: 0.005
  49. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal. Cancer. 2013 Nov 01; 119(21):3769-75.
    View in: PubMed
    Score: 0.005
  50. A novel risk-adjusted nomogram for rectal cancer surgery outcomes. JAMA Surg. 2013 Aug; 148(8):769-77.
    View in: PubMed
    Score: 0.005
  51. An individualized conditional survival calculator for patients with rectal cancer. Dis Colon Rectum. 2013 May; 56(5):551-9.
    View in: PubMed
    Score: 0.004
  52. Metformin use and improved response to therapy in rectal cancer. Cancer Med. 2013 Feb; 2(1):99-107.
    View in: PubMed
    Score: 0.004
  53. Global quantitative assessment of the colorectal polyp burden in familial adenomatous polyposis by using a web-based tool. Gastrointest Endosc. 2013 Mar; 77(3):455-63.
    View in: PubMed
    Score: 0.004
  54. Superior mesenteric artery syndrome after ileal pouch anal anastomosis. Am Surg. 2013 Jan; 79(1):E14-6.
    View in: PubMed
    Score: 0.004
  55. 99mTc-IMMU-4 monoclonal antibody scan in colorectal cancer. A prospective study. Arch Surg. 1992 Nov; 127(11):1321-4.
    View in: PubMed
    Score: 0.004
  56. ACR appropriateness criteria???resectable rectal cancer. Radiat Oncol. 2012 Sep 24; 7:161.
    View in: PubMed
    Score: 0.004
  57. Prognostic significance of anastomotic recurrence from colorectal adenocarcinoma. Dis Colon Rectum. 1992 Sep; 35(9):838-42.
    View in: PubMed
    Score: 0.004
  58. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol. 2012 Sep; 19(9):2814-21.
    View in: PubMed
    Score: 0.004
  59. Intrathecal phenol rhizotomy for management of pain in recurrent unresectable carcinoma of the rectum. Surg Gynecol Obstet. 1991 Jul; 173(1):41-4.
    View in: PubMed
    Score: 0.004
  60. Feasibility of an expressive-disclosure group intervention for post-treatment colorectal cancer patients: results of the Healthy Expressions study. Cancer. 2011 Nov 01; 117(21):4993-5002.
    View in: PubMed
    Score: 0.004
  61. Benign parotid tumors: a 24-year experience. J Surg Oncol. 1991 Mar; 46(3):159-61.
    View in: PubMed
    Score: 0.004
  62. Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer. 2011 Aug 15; 117(16):3713-22.
    View in: PubMed
    Score: 0.004
  63. Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis. Fam Cancer. 2010 Jun; 9(2):99-107.
    View in: PubMed
    Score: 0.004
  64. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg. 2010 Jun; 210(6):934-41.
    View in: PubMed
    Score: 0.004
  65. Recurrent malignant salivary gland neoplasms. J Surg Oncol. 1989 Oct; 42(2):92-5.
    View in: PubMed
    Score: 0.004
  66. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Radiat Oncol Biol Phys. 2010 May 01; 77(1):60-5.
    View in: PubMed
    Score: 0.003
  67. Management and outcomes of anorectal infection in the cancer patient. Ann Surg Oncol. 2009 Oct; 16(10):2752-8.
    View in: PubMed
    Score: 0.003
  68. Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical course. Int J Radiat Oncol Biol Phys. 2009 Jul 01; 74(3):818-23.
    View in: PubMed
    Score: 0.003
  69. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol. 2008 Nov 10; 26(32):5254-60.
    View in: PubMed
    Score: 0.003
  70. Re: A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda Guidelines. J Natl Cancer Inst. 1998 Jun 17; 90(12):939-40.
    View in: PubMed
    Score: 0.003
  71. Outcomes of immediate vertical rectus abdominis myocutaneous flap reconstruction for irradiated abdominoperineal resection defects. J Am Coll Surg. 2008 Apr; 206(4):694-703.
    View in: PubMed
    Score: 0.003
  72. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):1175-80.
    View in: PubMed
    Score: 0.003
  73. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol. 2008 Jan 20; 26(3):368-73.
    View in: PubMed
    Score: 0.003
  74. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer. Ann Surg Oncol. 2008 Jan; 15(1):46-51.
    View in: PubMed
    Score: 0.003
  75. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys. 2007 Jul 01; 68(3):794-800.
    View in: PubMed
    Score: 0.003
  76. Is screening for thyroid carcinoma indicated in familial adenomatous polyposis? The Leeds Castle Polyposis Group. Int J Colorectal Dis. 1997; 12(4):240-2.
    View in: PubMed
    Score: 0.003
  77. Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal. Ann Surg Oncol. 2007 Feb; 14(2):478-83.
    View in: PubMed
    Score: 0.003
  78. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):762-71.
    View in: PubMed
    Score: 0.003
  79. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys. 2006 Dec 01; 66(5):1378-83.
    View in: PubMed
    Score: 0.003
  80. Genomic profiles of colorectal cancers differ based on patient smoking status. Cancer Genet Cytogenet. 2006 Jul 15; 168(2):98-104.
    View in: PubMed
    Score: 0.003
  81. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol. 2006 Jun; 29(3):219-24.
    View in: PubMed
    Score: 0.003
  82. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiol Biomarkers Prev. 2006 May; 15(5):886-91.
    View in: PubMed
    Score: 0.003
  83. Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum. 2006 Feb; 49(2):175-82.
    View in: PubMed
    Score: 0.003
  84. IGF1 gene polymorphism and risk for hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst. 2006 Jan 18; 98(2):139-43.
    View in: PubMed
    Score: 0.003
  85. ATM polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States). Cancer Causes Control. 2005 Aug; 16(6):749-53.
    View in: PubMed
    Score: 0.003
  86. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys. 2004 Nov 15; 60(4):1098-105.
    View in: PubMed
    Score: 0.002
  87. A prospective evaluation of radiocolloid and immunohistochemical staining in colon carcinoma lymphatic mapping. Cancer. 2004 May 15; 100(10):2104-9.
    View in: PubMed
    Score: 0.002
  88. Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg. 2004 Jan; 8(1):56-62; discussion 62-3.
    View in: PubMed
    Score: 0.002
  89. Chemoradiation for adenocarcinoma of the anus. Int J Radiat Oncol Biol Phys. 2003 Mar 01; 55(3):669-78.
    View in: PubMed
    Score: 0.002
  90. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer. 2003 Jan 15; 97(2):517-24.
    View in: PubMed
    Score: 0.002
  91. Is abdominoperineal resection a good option for stage IV adenocarcinoma of the distal rectum? J Surg Oncol. 2002 Sep; 81(1):3-7.
    View in: PubMed
    Score: 0.002
  92. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut. 2002 Jun; 50(6):857-60.
    View in: PubMed
    Score: 0.002
  93. Absorbable mesh sling prevents radiation-induced bowel injury during "sandwich" chemoradiation for rectal cancer. Arch Surg. 2000 Oct; 135(10):1212-7.
    View in: PubMed
    Score: 0.002
  94. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000 Jun 29; 342(26):1946-52.
    View in: PubMed
    Score: 0.002
  95. Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut. 2000 May; 46(5):656-60.
    View in: PubMed
    Score: 0.002
  96. p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma. Cancer. 2000 Apr 15; 88(8):1814-9.
    View in: PubMed
    Score: 0.002
  97. Photodynamic therapy for residual neoplasms of the perianal skin. Dis Colon Rectum. 2000 Apr; 43(4):499-502.
    View in: PubMed
    Score: 0.002
  98. Sexual dysfunction, informed consent and multimodality therapy for rectal cancer. Am J Surg. 2000 Apr; 179(4):271-4.
    View in: PubMed
    Score: 0.002
  99. Large bowel adenocarcinoma metastases presenting as appendicitis. J Clin Oncol. 1999 Aug; 17(8):2623-4.
    View in: PubMed
    Score: 0.002
  100. Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer. JAMA. 1999 Jun 23-30; 281(24):2316-20.
    View in: PubMed
    Score: 0.002
  101. Accuracy of biopsy and cytology for the preoperative diagnosis of colorectal adenocarcinoma. J Surg Oncol. 1999 May; 71(1):46-9.
    View in: PubMed
    Score: 0.002
  102. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer. Int J Cancer. 1999 Jan 18; 80(2):183-7.
    View in: PubMed
    Score: 0.002
  103. Utility of routine postoperative laboratory studies in patients undergoing potentially curative resection for adenocarcinoma of the colon and rectum. Cancer Invest. 1999; 17(2):102-9.
    View in: PubMed
    Score: 0.002
  104. Prognostic factors affecting survival in patients with colorectal carcinomatosis. Cancer Invest. 1999; 17(4):249-52.
    View in: PubMed
    Score: 0.002
  105. Long-term survival in patients with ovarian metastases from colorectal carcinoma. Ann Surg Oncol. 1998 Dec; 5(8):695-8.
    View in: PubMed
    Score: 0.002
  106. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer. 1998 Jul 15; 83(2):259-66.
    View in: PubMed
    Score: 0.002
  107. Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer. Cancer Res. 1998 Mar 01; 58(5):997-1003.
    View in: PubMed
    Score: 0.002
  108. Intraoperative endoscopy in the management of patients with colorectal disease. Cancer Invest. 1998; 16(1):1-5.
    View in: PubMed
    Score: 0.002
  109. Complications of absorbable pelvic mesh slings following surgery for rectal carcinoma. Dis Colon Rectum. 1997 Nov; 40(11):1336-41.
    View in: PubMed
    Score: 0.002
  110. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees. Cancer Res. 1997 Sep 01; 57(17):3798-803.
    View in: PubMed
    Score: 0.002
  111. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC. Ann Surg. 1997 Feb; 225(2):202-7.
    View in: PubMed
    Score: 0.001
  112. Genomic instability in sporadic colorectal cancer quantitated by inter-simple sequence repeat PCR analysis. Genes Chromosomes Cancer. 1997 Jan; 18(1):19-29.
    View in: PubMed
    Score: 0.001
  113. Primary signet-ring cell carcinoma of the colon and rectum. Ann Surg Oncol. 1996 Jul; 3(4):344-8.
    View in: PubMed
    Score: 0.001
  114. Utility of mapping lymph nodes cleared from rectal adenocarcinoma specimens. Surg Oncol. 1996 Jun; 5(3):123-6.
    View in: PubMed
    Score: 0.001
  115. Postoperative complications after splenectomy for hematologic malignancies. Ann Surg. 1996 Mar; 223(3):290-6.
    View in: PubMed
    Score: 0.001
  116. Wide perineal dissection and its effect on local recurrence following potentially curative abdominoperineal resection for rectal adenocarcinoma. Cancer Invest. 1996; 14(1):1-5.
    View in: PubMed
    Score: 0.001
  117. Curative resection for stage I rectal cancer: natural history, prognostic factors, and recurrence patterns. Cancer Invest. 1996; 14(5):491-7.
    View in: PubMed
    Score: 0.001
  118. Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT. Radiology. 1995 Dec; 197(3):688-92.
    View in: PubMed
    Score: 0.001
  119. Patterns of colorectal liver metastases according to Couinaud's segments. Dis Colon Rectum. 1995 Mar; 38(3):245-8.
    View in: PubMed
    Score: 0.001
  120. Prognosis and recurrence patterns of anal adenocarcinoma. Am J Surg. 1995 Feb; 169(2):233-7.
    View in: PubMed
    Score: 0.001
  121. A phase II and pharmacokinetic study of 6S-leucovorin plus 5-fluorouracil in patient with colorectal carcinoma. Invest New Drugs. 1995; 13(2):149-55.
    View in: PubMed
    Score: 0.001
  122. Inguinal lymph node metastases from adenocarcinoma of the rectum. Am J Surg. 1994 Sep; 168(3):285-7.
    View in: PubMed
    Score: 0.001
  123. Primary colorectal non-Hodgkin's lymphoma. Ann Surg Oncol. 1994 May; 1(3):222-8.
    View in: PubMed
    Score: 0.001
  124. Phase I and pharmacokinetic evaluation of floxuridine/leucovorin given on the Roswell Park weekly regimen. Cancer Chemother Pharmacol. 1994; 34(3):261-5.
    View in: PubMed
    Score: 0.001
  125. Nasogastric decompression following elective colorectal surgery: a prospective randomized study. Am Surg. 1993 Oct; 59(10):632-5.
    View in: PubMed
    Score: 0.001
  126. Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma. Cancer. 1993 Sep 01; 72(5):1543-6.
    View in: PubMed
    Score: 0.001
  127. Morbidity and mortality following abdominoperineal resection for rectal adenocarcinoma. Am Surg. 1993 Jul; 59(7):400-4.
    View in: PubMed
    Score: 0.001
  128. Isolation of Inoue-Melnick virus from colorectal carcinoma tissues. Cancer. 1993 Mar 15; 71(6):1960-3.
    View in: PubMed
    Score: 0.001
  129. Altered immunoglobulin A (IgA-1) levels in patients with advanced colorectal adenocarcinoma presenting with normal preoperative levels of carcinoembryonic antigen (CEA). Surg Oncol. 1993; 2(1):19-23.
    View in: PubMed
    Score: 0.001
  130. Endoscopic laser treatment for palliation of colorectal adenocarcinoma. Surg Oncol. 1993; 2(1):25-30.
    View in: PubMed
    Score: 0.001
  131. Photodynamic therapy in the management of neoplasms of the perianal skin. Arch Surg. 1992 Dec; 127(12):1436-8.
    View in: PubMed
    Score: 0.001
  132. Gastroduodenal polyps in familial adenomatous polyposis. Surg Oncol. 1992 Oct; 1(5):357-61.
    View in: PubMed
    Score: 0.001
  133. The use of the major anoxic stress response protein P34, the K isozyme of lactate dehydrogenase, and carcinoembryonic antigen in the follow-up of patients with colorectal adenocarcinoma. Cancer. 1992 Oct 01; 70(7):1834-7.
    View in: PubMed
    Score: 0.001
  134. Papillary cystic neoplasm of the pancreas. A report of a case presenting with carcinomatosis. Am Surg. 1989 Sep; 55(9):552-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.